Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to possibly further improve the clinical outcome and explore the incidence of OHSS in patients, who have final oocyte maturation with GnRHa (Buserelin) in GnRH antagonist IVF/ICSI cycles


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00627406
Study type Interventional
Source Regionshospitalet Viborg, Skive
Contact
Status Completed
Phase Phase 4
Start date January 2009
Completion date December 2011